Xiaoli Shen

1.4k total citations
39 papers, 803 citations indexed

About

Xiaoli Shen is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xiaoli Shen has authored 39 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Immunology. Recurrent topics in Xiaoli Shen's work include Bone health and treatments (7 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (5 papers). Xiaoli Shen is often cited by papers focused on Bone health and treatments (7 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (5 papers). Xiaoli Shen collaborates with scholars based in United States, China and Switzerland. Xiaoli Shen's co-authors include Miriam Falzon, Rolf König, R N Germain, Verónica A. Tovar Sepúlveda, Lihui Qian, Yue Ma, Dongfeng Zhang, Rosario Maroto, Ronald N. Germain and J. M. C. Plane and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Xiaoli Shen

36 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoli Shen United States 19 356 214 200 134 58 39 803
Christopher G. Fenton Norway 16 334 0.9× 183 0.9× 264 1.3× 176 1.3× 73 1.3× 30 814
Jessica L. Slack United States 12 273 0.8× 148 0.7× 176 0.9× 70 0.5× 35 0.6× 13 619
Michael Bernimoulin Switzerland 13 336 0.9× 126 0.6× 180 0.9× 133 1.0× 52 0.9× 17 714
Odile Blanchet France 20 432 1.2× 150 0.7× 179 0.9× 102 0.8× 41 0.7× 55 1.5k
Patrick Baum Germany 18 472 1.3× 105 0.5× 320 1.6× 172 1.3× 51 0.9× 29 971
Hong Xiao United States 15 615 1.7× 575 2.7× 107 0.5× 113 0.8× 88 1.5× 51 1.4k
Catherine Ross Canada 16 290 0.8× 109 0.5× 164 0.8× 53 0.4× 58 1.0× 37 936
Kevin Hu United States 10 385 1.1× 177 0.8× 144 0.7× 114 0.9× 76 1.3× 22 948
Marilyn Intengan United States 9 401 1.1× 173 0.8× 192 1.0× 105 0.8× 63 1.1× 12 679
Maria Concetta Cufaro Italy 12 400 1.1× 58 0.3× 87 0.4× 137 1.0× 30 0.5× 31 587

Countries citing papers authored by Xiaoli Shen

Since Specialization
Citations

This map shows the geographic impact of Xiaoli Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Shen more than expected).

Fields of papers citing papers by Xiaoli Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Shen. The network helps show where Xiaoli Shen may publish in the future.

Co-authorship network of co-authors of Xiaoli Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Shen. A scholar is included among the top collaborators of Xiaoli Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Shen. Xiaoli Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Xiaoli, David M. Bell, Hugh Coe, et al.. (2024). Measurement report: The Fifth International Workshop on Ice Nucleation phase 1 (FIN-01): intercomparison of single-particle mass spectrometers. Atmospheric chemistry and physics. 24(18). 10869–10891. 3 indexed citations
3.
Zhang, Qianlong, Yuqing Wang, Xiaoli Shen, et al.. (2023). Environmental exposure to per- and perfluoroalkyl substances in early pregnancy and newborn anogenital distance: A prospective cohort study. Environmental Science and Pollution Research. 30(44). 99704–99712. 3 indexed citations
4.
Murphy, Daniel M., Daniel J. Cziczo, K. D. Froyd, et al.. (2023). Metals from spacecraft reentry in stratospheric aerosol particles. Proceedings of the National Academy of Sciences. 120(43). e2313374120–e2313374120. 52 indexed citations
5.
Shen, Xiaoli, et al.. (2023). The bibliometric analysis of studies on intracytoplasmic sperm injection from 2002 to 2021. Frontiers in Endocrinology. 14. 1109623–1109623.
6.
Wang, Li-Chong, Shuhui Chen, Xiaoli Shen, et al.. (2020). M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme. Frontiers in Oncology. 10. 536875–536875. 67 indexed citations
7.
D’Alonzo, Donato, et al.. (2019). Hectd1 is essential for embryogenesis in mice. Gene Expression Patterns. 34. 119064–119064. 12 indexed citations
8.
Shen, Xiaoli, et al.. (2017). HECTD1 controls the protein level of IQGAP1 to regulate the dynamics of adhesive structures. Cell Communication and Signaling. 15(1). 2–2. 22 indexed citations
9.
Sun, Yang, Long Jin, Jiahua Liu, et al.. (2016). Interfering EZH2 Expression Reverses the Cisplatin Resistance in Human Ovarian Cancer by Inhibiting Autophagy. Cancer Biotherapy and Radiopharmaceuticals. 31(7). 246–252. 23 indexed citations
10.
Wu, Lei, Liang Yang, Yu Xiong, et al.. (2014). Annexin A5 promotes invasion and chemoresistance to temozolomide in glioblastoma multiforme cells. Tumor Biology. 35(12). 12327–12337. 24 indexed citations
11.
12.
Shen, Xiaoli, et al.. (2007). Increased cell survival, migration, invasion, and Akt expression in PTHrP-overexpressing LoVo colon cancer cell lines. Regulatory Peptides. 141(1-3). 61–72. 20 indexed citations
13.
Shen, Xiaoli & Miriam Falzon. (2006). PTH-related protein upregulates integrin α6β4 expression and activates Akt in breast cancer cells. Experimental Cell Research. 312(19). 3822–3834. 23 indexed citations
14.
Shen, Xiaoli & Miriam Falzon. (2003). PTH-related protein modulates PC-3 prostate cancer cell adhesion and integrin subunit profile. Molecular and Cellular Endocrinology. 199(1-2). 165–177. 42 indexed citations
15.
Shen, Xiaoli & Miriam Falzon. (2003). Parathyroid hormone-related protein upregulates integrin expression via an intracrine pathway in PC-3 prostate cancer cells. Regulatory Peptides. 113(1-3). 17–29. 27 indexed citations
16.
Sepúlveda, Verónica A. Tovar, Xiaoli Shen, & Miriam Falzon. (2002). Intracrine PTHrP Protects against Serum Starvation-Induced Apoptosis and Regulates the Cell Cycle in MCF-7 Breast Cancer Cells. Endocrinology. 143(2). 596–606. 74 indexed citations
17.
Maroto, Rosario, Xiaoli Shen, & Rolf König. (1999). Requirement for Efficient Interactions Between CD4 and MHC Class II Molecules for Survival of Resting CD4+ T Lymphocytes In Vivo and for Activation-Induced Cell Death. The Journal of Immunology. 162(10). 5973–5980. 22 indexed citations
18.
Gilfillan, Susan, Xiaoli Shen, & Rolf König. (1998). Selection and Function of CD4+ T Lymphocytes in Transgenic Mice Expressing Mutant MHC Class II Molecules Deficient in Their Interaction with CD4. The Journal of Immunology. 161(12). 6629–6637. 13 indexed citations
19.
Shen, Xiaoli, Bin Hu, P McPhie, et al.. (1996). Peptides corresponding to CD4-interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo. The Journal of Immunology. 157(1). 87–100. 32 indexed citations
20.
König, Rolf, Xiaoli Shen, & R N Germain. (1995). Involvement of both major histocompatibility complex class II alpha and beta chains in CD4 function indicates a role for ordered oligomerization in T cell activation.. The Journal of Experimental Medicine. 182(3). 779–787. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026